Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study

Only 30 percent of chronic diabetic foot ulcers heal after 20 weeks of standard treatment. Pirfenidone is a drug with biological, anti-inflammatory, and antifibrotic effects. The aim of this study was to evaluate the effect of topical pirfenidone added to conventional treatment in noninfected chroni...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Diabetes Res
Autors principals: Janka-Zires, Marcela, Almeda-Valdes, Paloma, Uribe-Wiechers, Ana Cecilia, Juárez-Comboni, Sonia Citlali, López-Gutiérrez, Joel, Escobar-Jiménez, Jarod Jazek, Gómez-Pérez, Francisco J.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958428/
https://ncbi.nlm.nih.gov/pubmed/27478849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7340641
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars